Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

The team proposed a prenatal depression detection method using the semantically enhanced option embedding (SEOE) model to ...

CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...

Effective treatments for people with serious depression who have not been helped by antidepressant medications have novel ...

The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.

Depression can be treated but the first step is determining whether symptoms are present. This test could help. Using the key below, answer the questions based on how strongly you agree or ...

The largest, most ethnically diverse, study of its kind has flagged hundreds of genetic variants that play a role in ...

(HealthDay News) — Approximately four in 10 patients with osteoarthritis (OA) or rheumatoid arthritis (RA) have anxiety, depression, or fibromyalgia, according to a study published online July 16 in ...

The U.S. Food and Drug Administration ( FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with ...

A new report studied depression levels across Europe and in older and younger individuals, with the outlook for France ...